315 related articles for article (PubMed ID: 25566802)
1. APOBEC3B: pathological consequences of an innate immune DNA mutator.
Burns MB; Leonard B; Harris RS
Biomed J; 2015; 38(2):102-10. PubMed ID: 25566802
[TBL] [Abstract][Full Text] [Related]
2. Ancestral APOBEC3B Nuclear Localization Is Maintained in Humans and Apes and Altered in Most Other Old World Primate Species.
Auerbach AA; Becker JT; Moraes SN; Moghadasi SA; Duda JM; Salamango DJ; Harris RS
mSphere; 2022 Dec; 7(6):e0045122. PubMed ID: 36374108
[TBL] [Abstract][Full Text] [Related]
3. Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.
Akre MK; Starrett GJ; Quist JS; Temiz NA; Carpenter MA; Tutt AN; Grigoriadis A; Harris RS
PLoS One; 2016; 11(5):e0155391. PubMed ID: 27163364
[TBL] [Abstract][Full Text] [Related]
4. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.
Chan K; Roberts SA; Klimczak LJ; Sterling JF; Saini N; Malc EP; Kim J; Kwiatkowski DJ; Fargo DC; Mieczkowski PA; Getz G; Gordenin DA
Nat Genet; 2015 Sep; 47(9):1067-72. PubMed ID: 26258849
[TBL] [Abstract][Full Text] [Related]
5. Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses.
Verhalen B; Starrett GJ; Harris RS; Jiang M
J Virol; 2016 Jul; 90(14):6379-6386. PubMed ID: 27147740
[TBL] [Abstract][Full Text] [Related]
6. A Tumor-Promoting Phorbol Ester Causes a Large Increase in APOBEC3A Expression and a Moderate Increase in APOBEC3B Expression in a Normal Human Keratinocyte Cell Line without Increasing Genomic Uracils.
Siriwardena SU; Perera MLW; Senevirathne V; Stewart J; Bhagwat AS
Mol Cell Biol; 2019 Jan; 39(1):. PubMed ID: 30348839
[TBL] [Abstract][Full Text] [Related]
7. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.
Law EK; Sieuwerts AM; LaPara K; Leonard B; Starrett GJ; Molan AM; Temiz NA; Vogel RI; Meijer-van Gelder ME; Sweep FC; Span PN; Foekens JA; Martens JW; Yee D; Harris RS
Sci Adv; 2016 Oct; 2(10):e1601737. PubMed ID: 27730215
[TBL] [Abstract][Full Text] [Related]
8. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
Adolph MB; Love RP; Feng Y; Chelico L
Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
[TBL] [Abstract][Full Text] [Related]
9. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
[TBL] [Abstract][Full Text] [Related]
10. APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.
Hoopes JI; Cortez LM; Mertz TM; Malc EP; Mieczkowski PA; Roberts SA
Cell Rep; 2016 Feb; 14(6):1273-1282. PubMed ID: 26832400
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.
Butt Y; Sakhtemani R; Mohamad-Ramshan R; Lawrence MS; Bhagwat AS
Nat Commun; 2024 Mar; 15(1):2369. PubMed ID: 38499553
[TBL] [Abstract][Full Text] [Related]
12. DNA replication stress: a source of APOBEC3B expression in breast cancer.
Cescon DW; Haibe-Kains B
Genome Biol; 2016 Sep; 17(1):202. PubMed ID: 27716362
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer.
Harris RS
Breast Cancer Res; 2015 Jan; 17(1):8. PubMed ID: 25848704
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation.
Matsumoto T; Shirakawa K; Yokoyama M; Fukuda H; Sarca AD; Koyabu S; Yamazaki H; Kazuma Y; Matsui H; Maruyama W; Nagata K; Tanabe F; Kobayashi M; Shindo K; Morishita R; Sato H; Takaori-Kondo A
Sci Rep; 2019 Jun; 9(1):8307. PubMed ID: 31165764
[TBL] [Abstract][Full Text] [Related]
15. Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.
Carpenter MA; Temiz NA; Ibrahim MA; Jarvis MC; Brown MR; Argyris PP; Brown WL; Starrett GJ; Yee D; Harris RS
PLoS Genet; 2023 Nov; 19(11):e1011043. PubMed ID: 38033156
[TBL] [Abstract][Full Text] [Related]
16. Strand-biased cytosine deamination at the replication fork causes cytosine to thymine mutations in Escherichia coli.
Bhagwat AS; Hao W; Townes JP; Lee H; Tang H; Foster PL
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2176-81. PubMed ID: 26839411
[TBL] [Abstract][Full Text] [Related]
17. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.
Buisson R; Lawrence MS; Benes CH; Zou L
Cancer Res; 2017 Sep; 77(17):4567-4578. PubMed ID: 28698210
[TBL] [Abstract][Full Text] [Related]
18. Acute expression of human APOBEC3B in mice results in RNA editing and lethality.
Alonso de la Vega A; Temiz NA; Tasakis R; Somogyi K; Salgueiro L; Zimmer E; Ramos M; Diaz-Jimenez A; Chocarro S; Fernández-Vaquero M; Stefanovska B; Reuveni E; Ben-David U; Stenzinger A; Poth T; Heikenwälder M; Papavasiliou N; Harris RS; Sotillo R
Genome Biol; 2023 Nov; 24(1):267. PubMed ID: 38001542
[TBL] [Abstract][Full Text] [Related]
19. Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes.
Sanchez A; Ortega P; Sakhtemani R; Manjunath L; Oh S; Bournique E; Becker A; Kim K; Durfee C; Temiz NA; Chen XS; Harris RS; Lawrence MS; Buisson R
Nat Commun; 2024 Mar; 15(1):2370. PubMed ID: 38499542
[TBL] [Abstract][Full Text] [Related]
20. APOBEC3B is an enzymatic source of mutation in breast cancer.
Burns MB; Lackey L; Carpenter MA; Rathore A; Land AM; Leonard B; Refsland EW; Kotandeniya D; Tretyakova N; Nikas JB; Yee D; Temiz NA; Donohue DE; McDougle RM; Brown WL; Law EK; Harris RS
Nature; 2013 Feb; 494(7437):366-70. PubMed ID: 23389445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]